Novartis Cosentyx® receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement